Advent Technologies Holdings, Inc. (ADN)
NASDAQ: ADN · IEX Real-Time Price · USD
0.166
-0.012 (-6.52%)
At close: Apr 19, 2024, 4:00 PM
0.165
-0.002 (-1.02%)
After-hours: Apr 19, 2024, 7:21 PM EDT
Company Description
Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets in North America, Europe, and Asia.
It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems.
The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, including membrane electrode assemblies, bipolar plates, and reformers, as well as provides fuel-cell stack assembly and testing services.
It serves stationary power, portable power, automotive, aviation, energy storage, and sensor markets.
The company is headquartered in Boston, Massachusetts.
Advent Technologies Holdings, Inc.
Country | United States |
Founded | 2006 |
Industry | Utilities - Renewable |
Sector | Utilities |
Employees | 175 |
CEO | Dr. Vassilios Gregoriou Ph.D. |
Contact Details
Address: 500 Rutherford Avenue, Suite 102 Boston, Massachusetts 02129 United States | |
Phone | 857-264-7035 |
Website | advent.energy |
Stock Details
Ticker Symbol | ADN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001744494 |
CUSIP Number | 00788A105 |
ISIN Number | US00788A1051 |
Employer ID | 83-0982969 |
SIC Code | 3690 |
Key Executives
Name | Position |
---|---|
Dr. Vassilios Gregoriou Ph.D. | Chief Executive Officer and Chairman |
James F. Coffey J.D. | Chief Operating Officer, General Counsel and Corporate Secretary |
Dr. Emory Sayre De Castro Ph.D. | Chief Technology Officer and Executive Director |
Dr. Christos Kaskavelis Ph.D. | Chief Strategy Officer |
Dr. Panoraia Gourdoupi Ph.D. | Senior Vice President of Corporate Business Development - Advent Technologies SA and Director |
Morten Hougaard Sorensen | Senior Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 1, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Mar 29, 2024 | DEF 14A | Other definitive proxy statements |
Mar 18, 2024 | PRE 14A | Other preliminary proxy statements |
Mar 12, 2024 | 8-K | Current Report |
Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 25, 2024 | 8-K | Current Report |
Jan 17, 2024 | 8-K/A | [Amend] Current report |
Jan 11, 2024 | 8-K | Current Report |
Jan 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Dec 28, 2023 | 424B5 | Filing |